| dc.contributor.author | STOP-COVID19 Investigators | |
| dc.date.accessioned | 2023-02-15T14:29:01Z | |
| dc.date.available | 2023-02-15T14:29:01Z | |
| dc.date.issued | 2022-12-01 | |
| dc.identifier.citation | STOP-COVID19 Investigators 2022 , ' Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19 : a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial ' , The Lancet. Respiratory medicine , vol. 10 , no. 12 , pp. 1119-1128 . https://doi.org/10.1016/S2213-2600(22)00261-2 | en |
| dc.identifier.issn | 2213-2600 | |
| dc.identifier.other | PURE: 223831899 | |
| dc.identifier.other | PURE UUID: ca8f23e5-2323-493a-b33a-13c854327571 | |
| dc.identifier.other | Scopus: 85142783776 | |
| dc.identifier.other | PubMed: 36075243 | |
| dc.identifier.uri | https://hdl.handle.net/2164/20056 | |
| dc.description | Acknowledgments This study was funded by an investigator-initiated research grant from Insmed (Bridgewater, NJ, USA). The authors acknowledge Stephen Senn (Edinburgh, UK) for independent statistical advice and Alex McConnachie (University of Glasgow, Glasgow, UK), Aran Singanayagam (Imperial College, London, UK), Oriol Sibila (Hospital Clínic Barcelona, Barcelona, Spain), and Petra Rauchhaus (University of Dundee, Dundee, UK) for serving as the independent data monitoring committee. The STOP-COVID19 study was designated an urgent public health priority study by the UK National Institute for Health and Care Research. The authors acknowledge the funding and logistical support from the UK National Institute for Health and Care Research. unding Sponsored by the University of Dundee and supported through an Investigator Initiated Research award from Insmed, Bridgewater, NJ; STOP-COVID19 trial. Funding Sponsored by the University of Dundee and supported through an Investigator Initiated Research award from Insmed, Bridgewater, NJ; STOP-COVID19 trial. | en |
| dc.format.extent | 10 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | The Lancet. Respiratory medicine | en |
| dc.rights | Under a Creative Commons license https://creativecommons.org/licenses/by/4.0/ | en |
| dc.subject | R Medicine (General) | en |
| dc.subject | Pulmonary and Respiratory Medicine | en |
| dc.subject | Supplementary Data | en |
| dc.subject.lcc | R1 | en |
| dc.title | Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19 : a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial | en |
| dc.type | Journal article | en |
| dc.contributor.institution | University of Aberdeen.Health Services Research Unit | en |
| dc.description.status | Peer reviewed | en |
| dc.description.version | Publisher PDF | en |
| dc.identifier.doi | https://doi.org/10.1016/S2213-2600(22)00261-2 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85142783776&partnerID=8YFLogxK | en |
| dc.identifier.vol | 10 | en |
| dc.identifier.iss | 12 | en |
